OPtimizing Aldosterone Receptor Antagonist Therapy by Sodium Zirconium Cyclosilicate in Heart Failure
OPtimizing Aldosterone Receptor Antagonist Therapy by Sodium Zirconium Cyclosilicate in Heart Failure
Active, not recruiting · NCT04789239 · Registry updated 2025-07-04Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| OPtimizing Aldosterone Receptor Antagonist Therapy by Sodium Zirconium Cyclosilicate in Heart Failure | Hyperkalemia, Nutritional and Metabolic Diseases, Water-Electrolyte Imbalance, cardiovascular disorder, heart disorder, heart failure, metabolic disease | Active, not recruiting | Phase 2 | 2025-07-04 | NCT04789239 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| AstraZeneca | 806 |
| Göteborg University | 174 |
| Michael Fu | 1 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Sahlgrenska University Hospital-Ostra Hospital | Gothenburg | Sweden | 1 |
| Section of Cardiology, Sahlgrenska University Hospital-Östra Hospital | Gothenburg | Sweden | 1 |